Table 4.
PFS and OS in relation to haplotypes.
Progression-free survival | Overall survival | |||||||
---|---|---|---|---|---|---|---|---|
Median PFS (95%CI) | HR (95% CI) | p | HR* (95% CI) | p* | Median OS (95%CI) | HR (95% CI) | p | |
H1/H1 | 13.9 (12.2–19.3) | 0.73 (0.50–1.08) | 0.12 | 28.4 (18.6–38.6) | 0.86 (0.56–1.32) | |||
Other | 11.6 (10.4–13.1) | 1.00 | 21.1 (17.3–29.8) | 1.00 | 0.49 | |||
H2/H2 | 9.59 (6.9-NA) | 2.25 (1.26–4.03) | 0.006 | 2.83 (1.33–5.99) | 15.2 (9.79-NA) | 1.63 (0.91–2.90) | ||
Other | 12.52 (11.6–14) | 1.00 | 1.00 | 0.006 | 24.4 (19.75 -30.3) | 1.00 | 0.1 | |
H1/H1 + H2/H2 | 12.3 (9.76–14.8) | 0.95 (0.67–1.34) | 0.75 | 22.6 (16.7–37.8) | 1.05 (0.72–1.53) | |||
Other | 12.0 (11.2–13.9) | 1.00 | 23.4 (18.9–30.3) | 1.00 | 0.8 |
H1/H1, Haplo1/Haplo1; H2/H2, Haplo2/Haplo2; H1/H1 + H2/H2, Haplo1/Haplo1 + Haplo2/Haplo2.
*Ajusted HR and p-value.